A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

Abstract Our previous work identified a 13-gene miRNA signature predictive of response to the epidermal growth factor receptor (EGFR) inhibitor, erlotinib, in Non-Small Cell Lung Cancer cell lines. Bioinformatic analysis of the signature showed a functional convergence on TGFβ canonical signalling....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Madeline Krentz Gober, James P. Collard, Katherine Thompson, Esther P. Black
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/63a108947c5040c98b9e1ac1ac2632b6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!